farrell, I have been reading between the lines regarding the PR, What about a scenario like, "expanded IND", once the human trial is complete and they have done further testing to include the Virus and common cold therapy:
"clinical stage biopharmaceutical company, today announces additional independent preliminary laboratory research suggests Brilacidin, the Company’s flagship defensin mimetic, has the potential to treat other endemic human coronaviruses (H-CoVs), such as those causing common colds, and not just SARS-CoV-2, the novel coronavirus responsible for the ongoing global COVID-19 pandemic."
Than we have the IBD for top to bottom, waiting in the, well...............(wings
"clinical stage biopharmaceutical company, today announces additional independent preliminary laboratory research suggests Brilacidin, the Company’s flagship defensin mimetic, has the potential to treat other endemic human coronaviruses (H-CoVs), such as those causing common colds, and not just SARS-CoV-2, the novel coronavirus responsible for the ongoing global COVID-19 pandemic."
Than we have the IBD for top to bottom, waiting in the, well...............(wings
3